Abbreviations used: ANOVA, analysis of variance; ET, endo thelin, ir, immunoreactive; MCAO, middle cerebral artery oc clusion; RIA, radioimmunoassay; SR, spontaneously hyperten sive rats.
Summary: Endothelin-1, a peptide exhibiting extremely potent cerebral vasoactive properties, is elevated in the cerebrospinal fluid after hemorrhagic stroke and impli cated in cerebral vasospasm. The purpose of this study was to determine changes in endothelin in ischemic rat brain by assaying endothelin tissue and extracellular lev els. Immunoreactive endothelin levels in ischemic brain tissue following permanent or transient focal ischemia produced by middle cerebral artery occlusion was deter mined. In addition, endothelin levels were assayed in stri atal extracellular fluid collected by microdialysis before, during, and after global ischemia produced by two-vessel occlusion combined with hypotension. Twenty-four hours after the onset of permanent middle cerebral artery occlusion, the ischemic cortex level (0.58 ± 0.27 fmoll mg protein) of immunoreactive endothelin was signifi cantly (p < 0.05) increased, by 100%, over that in the nonischemic cortex (0.29 ± 0.13 fmollmg protein). Tran-Endothelin (ET) is a 21-amino acid peptide orig inally isolated from porcine endothelial cells (Yan agisawa et aI., 1988) . Three isoforms of endothelin (i.e., ET-l, -2, and -3) have been identified in geno mic DNA (Inoue et aI., 1989) . Both ET-l and ET-3 are present in the brain (Matsumoto et aI., 1989; Shinmi et aI., 1989; Takahashi et aI., 1990) and spe cific binding sites have been identified (Koseki et sient artery occlusion for 80 min with reperfusion for 24 h also resulted in a similar significant (p < 0.05) increase, 78%, in immunoreactive endothelin in the ischemic zone. Global forebrain ischemia significantly (p < 0.05) in creased the level of immunoreactive endothelin collected in striatal microdialysis perfusate, from a basal level of 14.6 ± 6.7 to 26.5 ± 7.7 and 26.2 ± 7.4 amolllLl (i.e. 82 and 79%). These changes reflect the relative picomolar extracellular concentration increases during ischemia and following reperfusion, respectively. This is the first dem onstration of elevated levels of endothelin in focal isch emic tissue and in the extracellular fluid in global isch emia and suggests a role of the peptide in ischemic and postischemic derangements of cerebral vascular function and tissue injury. Key Words: Endothelin-Focal isch emia-Global ischemia-Middle cerebral artery occlu sion-Neurological deficits-Postischemic hypoperfu sion. aI., 1989; Lysko and Nambi, 1992) . ET in the cen tral nervous system (Giaid et al., 1989; Matsumoto et aI., 1989; Shinmi et aI., 1989; Takahashi et aI., 1990; Lee et aI., 1990; Yoshimoto et aI., 1990) is localized in neurons and microvessel endothelial cells (Lee et aI., 1990; Yoshimoto et al., 1990) . In creased glial endothelin occurs during development and active gliosis (Cintra et aI., 1989; MacCumber et aI., 1990) . In addition to potent vasoconstriction (Yanagisawa et aI., 1988) , the ET peptides are also neuromodulatory Greenberg et aI., 1992) ; and involved in a wide va riety of physiologic and pathophysiologic reactions in the brain (Gulati and Srimal, 1992) . At least three subtypes of ET receptors have been identified on the basis of cloning, structural and tissue location differences, functionally different sensitivities to ET-l, -2, and -3, and apparent interactions with dif ferent G-proteins (Jones et al., 199 1; Sokolovsky, 199 1) .
The pharmacological activities of ET-l are ex pected to contribute to neuronal injury associated with ischemic and hemorrhagic stroke (Greenberg et aI., 1992) . ET can cause subarachnoid hemor rhage in the anesthetized rabbit (Huneidi et aI., 199 1) , it is increased in both the plasma (Masaoka et at, 1989; Fujimori et aI., 1990) ; and the cerebrospi nal fluid (Fujimori et aI., 1990; Suzuki et aI., 1990a, b) after subarachnoid hemorrhage related to vaso spasm (Suzuki et al., 1992) , and the experimental application of ET -1 into the brain produces focal infarctions (Fuxe et aI., 199 1, 1992) . Since ET can produce prolonged vasospasm (Shigeno et aI., 1989; Asano et aI., 1990; Kobayashi et aI., 1990; Alafaci et aI., 199 1) , hypoperfusion (Willette and Sauer melch, 1990; Willette et aI., 1990) , and neuronal damage, it might exacerbate tissue damage in hem orrhagic and ischemic stroke. However, no infor mation is available regarding changes in the tissue and extracellular concentrations of ET in experi mental focal and global ischemia, respectively. In the present experiments, we measured tissue levels of ET in ischemic and nonischemic brain areas of rats subjected to either permanent or transient focal ischemia. In addition, the extracellular levels of ET were monitored using microdialysis of the striatal region in rats subjected to transient global ischemia.
MATERIALS AND METHODS
Surgical procedures for middle cerebral artery occlu sion (MCAD; permanent or 80-min transient with reper fusion) or sham surgery under pentobarbital anesthesia, with the body temperature maintained at 37°C, were as described previously (Barone et aI., 1991a (Barone et aI., ,b, 1992 and utilized spontaneously hypertensive rats (SH), 280-350 g, because of their increased sensitivity and decreased vari ability to focal ischemia damage (Rarone et aI., 1992) . Two separate neurological examinations were performed after 24 h to determine the severity of deficits following surgery. Contralateral forelimb deficits were measured using a neurological grade (Bederson et aI., 1986 ) and contralateral hindlimb deficits were measured using the hindlimb placement test (Barone et al., 1991a (Barone et al., ,b, 1992 . Animals were euthanized using sodium pentobarbital at 4 or 24 h postsurgery and the forebrain was dissected into four segments as described in detail previously (Barone et al., 1991a (Barone et al., , 1992 and outlined schematically in Fig. 1 . The four forebrain segments were immediately frozen in liquid nitrogen and stored at -80°C until assayed.
Male Wistar rats, 280-300 g, were subjected to 20 min of global cerebral ischemia by two-vessel occlusion com bined with systemic hypotension under halothane anes thesia as described previously (Globus et aI., 1989 (Globus et aI., , 1991 . Microdialysis probes were sterotaxically implanted bilat erally in the dorsolateral striata (CMNIO 4-mm dialysis membrane; Carnegie Medicine, Sweden) and perfused with Ringer's solution at a flow rate of 2 fl.Vmin (Carnegie Medicine). Following a 2-h stabilization period, 20 min of ischemia was produced by tightening carotid ligatures bi laterally and maintaining the mean arterial blood pressure at 45-50 mm Hg by gradual withdrawal of blood. Brain temperature was always 36-37°C (Busto et aI., 1987) . To permit postischemic reperfusion, the carotid ligatures were removed and the blood, also kept at 36-37°C, was reinfused to restore the mean arterial blood pressure to normal values. Microdialysis samples were collected at lO-min intervals, 30 min prior to ischemia, during the 20 min period of ischemia, and during the first 30 min and at the end of 1 and 2 h of recirculation. Samples were pooled together in each animal to represent the baseline, intra ischemic, early recirculation (30 min), and later recircu lation (1 and 2 h) treatment periods. The pooled samples were immediately frozen and stored at -80°C until as sayed. The dorsolateral striatal location of the microdial ysis probe was verified histologically in each euthanized animal at the end of the experiment.
For tissue immunoreactive (ir)-ET measurements, the forebrain segments following MCAD were extracted by boiling for 5 min in 2 vol of acetic acid (1 M) containing 0.01% Triton X-100. All four segments from each animal were always assayed together to reduce interassay vari ations. Tissues were homogenized immediately with a Polytron for 30-45 s and centrifuged at 48,000 g for 20 min. Supernatants were applied to a Sep-Pak C18 column (Waters) preactivated with 3 ml methanol, 2 ml water, and 2 ml 10% acetic acid. Columns were washed with 2 ml acetic acid and 3 ml ethyl acetate, and ET was eluted by washing the columns with 1.5 ml acetic acid/water/ trifluoroacetic acid (30170/0.1) evaporated to dryness and reconstituted to 1.0 ml with radioimmunoassay (RIA) buffer. For ir-ET measurements in microdialysis perfus ate, pooled individual time period aliquots from both di alysis probes were assayed directly for each animal. Pool ing of perfusate samples was necessary to provide per fusate volumes adequate for RIA.
ET levels were determined by a RIA specific for ir-ET. Antiserum specific for ET was prepared in rabbits with an ET (15-21)-KLH conjugate. Cross-reactivity of this anti body with either porcine big ET (1-39), or human big ET (1-38) was <0.001%. The antibody does recognize the C terminal of all ETs and, therefore, cross-reacts equally with ET-1, ET-2, and ET-3. The RIA buffer was 0.02 M boric acid (pH 7.4) containing 0.1% bovine serum albumin, 0.1% Tween 20, and 0.02% sodium azide. Stan dard ET-1 (American Peptides) or sample (100 fl.l) was incubated with 100 fl.l of antiserum (final dilution, 1:150,000) for 24 h at 4°C, then 100 fl.l of 125I_ET_1 (12,000-14,000 cpm; New England Nuclear) was added to each tube and incubated for 18 h at 4°C. Donkey anti rabbit serum coated on magnetized polymer particles (Amersham Corp.) was incubated in each tube for 10 min and the antibody-bound fraction was separated magneti cally. The sensitivity of the assay was 1 fmoVtube, with the 50% intercept being approximately 4 fmoVtube. The relative recovery of tissue ET was approximately 80-85%.
Data are expressed as means ± SD for the indicated number of animals studied. ir-ET tissue levels are ex pressed as femtomoles (fmol) of ET per milligram of pro tein. Protein was determined by the method of Lowry et al. (1951) amoles per microliter of perfusate, (1 amol or atto mol is equivalent to to-18 mol). Statistical analysis of data was performed using an analysis of variance (ANOV A) fol lowed by a Dunnett's or Tukey test (Winer, 1971) , with a probability value p < 0.05 accepted as significant. Figure 1 illustrates ir-ET levels after 4 or 24 h of permanent or transient MCAO. A trend to in creased ir-ET (by 40 and 45%, respectively) was observed for the ischemic site (forebrain segment A) over the nonischemic site (segment B) after 4 h, but the trend was not statistically significant (p > 0.05). Also, no effects were observed 4 h after sham surgery (n = 5; A, B, C, and D segments were 0. 17 ± 0. 16, 0. 15 ± 0.02, 0.21 ± 0.20, and 0. 18 ± 0.09 fmollmg protein, respectively). After 24 h, signifi cant (p < 0.05) neurological deficits were produced by transient and permanent MCAO (Le., forelimb deficits of 1. 4 ± 1.0 and 1. 8 ± 0.4, respectively, compared to a sham value of 0. 1 ± 0. 2; hindlimb deficits of 0.8 ± 0.2 and 1.0 ± 0.00, compared to a sham value of 0.0 ± 0. 0) similar to that described previously (Barone et aI., 1991b (Barone et aI., , 1992 . Although no significant changes in tissue ir-ET were observed in the sham surgery group after 24 h (n = 14, A, B, C, and D segments were 0.29 ;±: 0. 11, 0.24 ;±: 0. 11, 0.27 ;±: 0.11, and 0.30 ;±: 0.11 fmol/mg protein, re spectively), significant (p < 0.05) increments in ir ET, 100 and 78%, were observed in the ischemic cortex compared to the nonischemic cortex follow ing 24-h permanent and transient MCAO, respec tively. Figure 2 illustrates the striatal microdialysis per fusate levels before, during, and after (i.e., during reperfusion) global ischemia using the two-vessel occlusion plus hypotension technique. Perfusate ir ET increased significantly (p < 0.05) both during the 20 min of global ischemia, by 82%, and during the second (1-and 2-h samples pooled together) reperfusion period, by 79%. During the initial reper fusion period (�30 min), ir-ET levels were not dif ferent from basal but significantly (p < 0.05) below those during the ischemia and later reperfusion pe riod.
RESULTS

DISCUSSION
This is the first demonstration of increased ET levels in focal stroke and its extracellular release in Brain extracellular fluid ir-ET levels were measured as amoles per microliter (1 amol = 10-1 8 mol) using microdi alysis. Measurements were made before, during, and after global ischemia produced by two-vessel occlusion with hy pothermia (n = 10). The treatment periods during bilateral microdialysis of the striatum were 30 min preischemia (Basal), 20 min of ischemia (Ischemia), 0-30 min of initial reperfusion (1 Reperf), and 60 and 120 min of later reperfu sion (2Reperf global ischemia. ir-ET tissue levels following per manent or transient focal ischemia tended to in crease at 4 h and were significantly increased by 24 h. Increased ET levels could exacerbate any subse quent ischemic events 24 h after a primary cerebral artery occlusion. One might speculate that early in creases in ET levels may compromise tissue perfu sion in the ischemic zone, but as yet there is no solid evidence to support this. Extracellular ir-ET in the global ischemic brain was normalized to amoles per microliter of perfusate (i.e., lO-18 mol/ I_d). Therefore, the perfusate ir-ET changes suggest that the relative picomolar concentration increases from baseline occurred during ischemia and the later period of reperfusion. Increases in ET during reperfusion may account for the hypoperfusion ob served previously in this model of forebrain isch emia (Pulsinelli et aI., 1982a (Pulsinelli et aI., , 1982b Frerichs et aI., 1992) . Transient forebrain ischemia in the gerbil produces a significant twofold increase in tissue ir ET levels (Willette et aI., 1992) , and transient bilat eral carotid artery occlusion in stroke-prone rats produces hippocampal ir-ET concomitant with neu ronal degeneration after 4 to 6 days of reperfusion (Yamashita et al., 1993) . Several patients with ce rebral infarction have exhibited an increase in cere brospinal fluid ET (Hirata et aI., 1990; Suzuki et aI., 1990b) . In subarachnoid hemorrhage, increased ce rebrospinal fluid ET is in the midpicomolar range (Suzuki et aI., 1990a,b) . Endothelin acts abluminally (Shigeno et al., 1989; to cause prolonged vasoconstriction and hypoperfusion in the brain mi crovasculature Willette et aI., 1990) and MCA (Robinson et al., 199 1) . Microinjections of ET-l (Hokfelt et aI., 1989; Kataoka et aI., 1989; Fuxe et aI., 199 1, 1992) pro duce marked nervous tissue damage, which may be due in part to the release of excitotoxic amino acids (Lin et aI., 1990) , and increased glial (Suppattapone et aI., 1989) and/or neuronal (Yue et aI., 1990) in tracellular calcium. However, the direct neurotoxic effect of ET is due primarily to its potent vasocon striction and associated local ischemic action (Hokfelt et aI., 1989; Fuxe et aI., 1992) , which might mimic vasospasm and transient ischemic attacks (Fuxe et al., 199 1) . The neurotoxin ibotenic acid produces ir-ET within degenerating pyramidal nerve cells and astroglia (Cintra et aI., 1989) . Other studies are required to elucidate not only the cellu lar origines) of ET in ischemia models, but also its potential role in exacerbating cerebral tissue dam age (Kataoka, 199 1) . Perhaps the cellular trophic actions of ET (Takuwa et al., 1989; Bobik et al., 1990 ) play a role in pathology and/or neurological repair mechanisms. Only the development of potent ET receptor antagonists will provide the tools nec essary to evaluate the role(s) of ET in cerebral isch emia.
